Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Mazindol
Also marketed in the EU under the name(s): Adipex Retard, Amfepramone, Amorphan Depot, Anoran, Anorex, Antiadipositum, Antiobes Retard, Apisate, Atractil, Aviposan, Bea - Kapseln Rot-weiss, Cafilon, Delgamer, Dicel, Diethylpropion Hydrochloride, Diethylpropion Poudre, Dietil - Retard, Dinintel, Dobesin, Drenur, Duromine, Exponcit N, Falagan, Fasupond, Fenproporex, Finedal, Grasmin, Incital, Ionamin, Linea, Menutil, Mirapront-N, Moderatan, Panbesy Nyscaps, Pesex-R, Plegine, Prefamone, Regenon, Rondimen, Schlank - Dragees Resana, Tegisec, Tenuate, Teronac, Vita - Schlanktropfen Schuck
Active substance: Mazindol
Indication: Adjunctive therapy to diet, in patients with obesity and a body mass index (BMI) of 30 kg/m2 or higher who have not responded to an appropriate weight-reducing regimen alone
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/12/1996 Referral (96)3608 of 9/12/1996
10/03/2000 Referral (2000)608 of 9/03/2000